Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: March

Request Number: A-2023-000619

Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practice (GMP) inspection of the Novo Nordisk Canada facility (Site A) on Argentina Rd, Mississauga, Ontario, starting around 03/20/2019.

Disposition: Disclosed in part

Number of pages: 115

Date modified: